|
ZNF280B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
2.084700E-03 |
| Normal-vs-Stage3 |
5.51909999999545E-05 |
| Normal-vs-Stage4 |
1.023350E-01 |
| Stage1-vs-Stage2 |
5.381400E-01 |
| Stage1-vs-Stage3 |
4.703400E-01 |
| Stage1-vs-Stage4 |
2.733400E-01 |
| Stage2-vs-Stage3 |
8.804800E-01 |
| Stage2-vs-Stage4 |
2.879800E-01 |
| Stage3-vs-Stage4 |
2.473400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
6.64179999887438E-08 |
| Normal-vs-Asian |
9.928400E-02 |
| Caucasian-vs-AfricanAmerican |
3.940600E-01 |
| Caucasian-vs-Asian |
8.483000E-01 |
| AfricanAmerican-vs-Asian |
6.670400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
3.14850367999497E-11 |
| Male-vs-Female |
1.252040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.26310000037844E-07 |
| Normal-vs-Extreme_Weight |
2.64721577991622E-12 |
| Normal-vs-Obese |
8.85459483512818E-11 |
| Normal-vs-Extreme_Obese |
9.715200E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.948000E-01 |
| Normal_Weight-vs-Obese |
8.344300E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.310000E-01 |
| Extreme_Weight-vs-Obese |
6.394300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.916400E-01 |
| Obese-vs-Extreme_Obese |
2.657700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.649200E-04 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
2.17603712826531E-14 |
| Normal-vs-Age(81-100Yrs) |
4.082200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.106600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.680200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.348300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.797300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.883000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.700830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
4.2215999995765E-07 |
| Normal-VS-KIRP CIMP |
3.271200E-01 |
| Normal-VS-Unclassified PRCC |
1.14599999490039E-08 |
| Type1 PRCC-VS-Type2 PRCC |
4.544300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.115870E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.499600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.066000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.848500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.572200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.54230000279665E-08 |
| Normal-vs-N1 |
1.157780E-03 |
| Normal-vs-N2 |
1.970190E-01 |
| N0-vs-N1 |
7.492600E-01 |
| N0-vs-N2 |
7.395400E-01 |
| N1-vs-N2 |
7.056200E-01 |
|
|
